Google
CGC — CANOPY GROWTH CORP (Healthcare >> Drug Manufacturers - Specialty & Generic)
CGC FAQ
What is CGC's ROE?
CANOPY GROWTH CORP reports a Return on Equity (ROE) of -37.69%.
What is CGC's dividend yield?
CANOPY GROWTH CORP offers a dividend yield of 0.00%.
What is CGC's Deepscope Quality Score?
Deepscope rates CGC's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CGC?
Deepscope's AI Timing Score for CGC is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CGC belong to?
CANOPY GROWTH CORP is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 0.95
Price
-0.00
(-0.14%)
Day Change
|
|
|---|
CGC, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 95 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.95 |
| PBV / Sector |
0.52 / 3.06
GREAT
|
| Earning Per Share | -0.09 |
| PE / Sector |
N/A / 27.11
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
5.98 M
GREAT
|
| Average 1W Daily Value |
4.33 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
43% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-07-02 11:09:28 |
| Symbol | CGC |
| Name | CANOPY GROWTH CORP |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 422.15 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 365.24 / 10,075.21 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8
Phone: 855 558 9333
Website: https://www.canopygrowth.com
Employees: 1,128
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
